Skip to main content

View full-text article in PMC

. 2017 Sep;23(9):10.18553/jmcp.2017.23.9.936. doi: 10.18553/jmcp.2017.23.9.936

TABLE 2.

MPR and PDC in P+ and P+ Augmented with LRx

	P+ Only	P+ Augmented with LRx	P Value
Mean MPR % (SD)
All patients (N = 965,785)	76.7 (27.1)	79.4 (26.2)	< 0.001
Patients new to statins^a (n = 186,063)	58.7 (33.0)	61.4 (33.2)	< 0.001
Mean PDC % (SD)
All patients (N = 965,785)	74.0 (26.0)	76.0 (25.2)	< 0.001
Patients new to statins (n = 186,063)	56.5 (31.6)	58.5 (31.6)	< 0.001

^aNew to statins using a 12-month washout and the P+ augmented with LRx data.

LRx = IMS longitudinal pharmacy point-of-sale prescription claims database; MPR = medication possession ratio; P+ = PharMetrics Plus claims database; PDC = proportion of days covered; SD = standard deviation.